JP2024543187A - タウタンパク質の異常リン酸化及び凝集の阻害物質 - Google Patents

タウタンパク質の異常リン酸化及び凝集の阻害物質 Download PDF

Info

Publication number
JP2024543187A
JP2024543187A JP2024531728A JP2024531728A JP2024543187A JP 2024543187 A JP2024543187 A JP 2024543187A JP 2024531728 A JP2024531728 A JP 2024531728A JP 2024531728 A JP2024531728 A JP 2024531728A JP 2024543187 A JP2024543187 A JP 2024543187A
Authority
JP
Japan
Prior art keywords
formula
compound
tau
nmr
sulfonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024531728A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543187A5 (cg-RX-API-DMAC10.html
Inventor
アンヌ、ワドゥアシ
ドゥルセ、パピー、ガルシア
グラディス、プルソー
サンドリーヌ、シャントピ
Original Assignee
ユニベルシテ ドゥ ピカルディ ジュール ベルヌ
ユニヴェルシテ・パリ・エ・クレテイユ・ヴァル・ドゥ・マルヌ
サントル、ナショナール、ド、ラ、ルシェルシュ、シアンティフィク、(セーエヌエルエス)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニベルシテ ドゥ ピカルディ ジュール ベルヌ, ユニヴェルシテ・パリ・エ・クレテイユ・ヴァル・ドゥ・マルヌ, サントル、ナショナール、ド、ラ、ルシェルシュ、シアンティフィク、(セーエヌエルエス) filed Critical ユニベルシテ ドゥ ピカルディ ジュール ベルヌ
Publication of JP2024543187A publication Critical patent/JP2024543187A/ja
Publication of JP2024543187A5 publication Critical patent/JP2024543187A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2024531728A 2021-11-29 2022-11-29 タウタンパク質の異常リン酸化及び凝集の阻害物質 Pending JP2024543187A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21306658.2 2021-11-29
EP21306658 2021-11-29
PCT/EP2022/083709 WO2023094699A1 (fr) 2021-11-29 2022-11-29 Inhibiteurs de la phosphorylation anormale et de l'agrégation de la protéine tau

Publications (2)

Publication Number Publication Date
JP2024543187A true JP2024543187A (ja) 2024-11-19
JP2024543187A5 JP2024543187A5 (cg-RX-API-DMAC10.html) 2025-11-28

Family

ID=78851140

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024531728A Pending JP2024543187A (ja) 2021-11-29 2022-11-29 タウタンパク質の異常リン酸化及び凝集の阻害物質

Country Status (6)

Country Link
US (1) US20250034194A1 (cg-RX-API-DMAC10.html)
EP (1) EP4441064A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024543187A (cg-RX-API-DMAC10.html)
CN (1) CN118922429A (cg-RX-API-DMAC10.html)
CA (1) CA3240163A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023094699A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240409505A1 (en) * 2023-06-12 2024-12-12 The Procter & Gamble Company Gluconamide sulfate surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686603A (en) * 1995-05-04 1997-11-11 Lever Brothers Company, Division Of Conopco, Inc. Sulfated polyhydroxy compounds as anionic surfactants and a process for their manufacture
WO2007115372A1 (en) * 2006-04-10 2007-10-18 Monash University A method of modulating beta-amyloid peptide production

Also Published As

Publication number Publication date
CN118922429A (zh) 2024-11-08
US20250034194A1 (en) 2025-01-30
CA3240163A1 (fr) 2023-06-01
WO2023094699A1 (fr) 2023-06-01
EP4441064A1 (fr) 2024-10-09

Similar Documents

Publication Publication Date Title
JP2022520518A (ja) パンテテイン誘導体及びその使用
HU193151B (en) Process for producing ganglyoside derivatives and pharmaceutical compositions containing them as active agents
US20220249411A1 (en) Calixarene compounds and uses thereof
JP2016536360A (ja) パントテン酸キナーゼ関連神経変性症(pkan)の治療のための安定なパンテテイン誘導体およびそのような化合物の合成方法
CA3146157A1 (en) Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications for the treatment of neurodegenerative diseases
TW201241005A (en) Methods for synthesizing molybdopterin precursor Z derivatives
US20250034194A1 (en) Inhibitors of abnormal phosphorylation and tau protein aggregation
CN111494380B (zh) Db-1在制备防治nlrp3炎症小体相关疾病的药物中的应用及其药物组合物
JP2009527563A (ja) ウイルス感染症を治療するのに有用な置換タラキサスタン
CN112218878A (zh) Ntcp抑制剂
JPH02200697A (ja) リゾガングリオシド誘導体
JP2008529998A (ja) トポイソメラーゼII触媒インヒビターとしての6−エーテル/チオエーテル−プリンおよび療法(therapy)におけるその用途
KR20180101416A (ko) Cftr 조절제 및 이의 이용 방법
JP2025505975A (ja) ニコチネート及びニコチンアミドリボシドベースの化合物及びその誘導体
TWI803858B (zh) 化合物及其醫藥用途
US20190211059A1 (en) Novel compounds for the treatment of neurodegenerative diseases
KR20090074226A (ko) 혈액응고를 방해하는 화합물
JP2004083465A (ja) Smアーゼインヒビターとしてのシホスタチンアナログ
JP6353849B2 (ja) Bace−1の阻害剤としての糖樹状クラスター化合物
US20150191446A1 (en) Seleno-compounds and therapeutic uses thereof
HU208834B (en) Process for producing dilysoganglioside derivatives and pharmaceutical compositions comprising such active ingredient
AU2017405304B2 (en) Heparan sulfate glycomimetic compounds and their pharmaceutical and cosmeceutical uses
CN104557897A (zh) 法舒地尔-硫辛酸二联体的合成及其应用
ES2629019T3 (es) Derivado de tiazinamida y composición farmacéutica y uso de los mismos
CN121270649A (zh) 一类万古霉素衍生物、其制备方法、药物组合物和用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251117

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251117